With $150M in the bank, Dalcor seeks phase III success with dalcetrapib

Read Article

Startup Aims to Revive Failed Drug

Read Article

Xagenic readies X1 molecular diagnostic beta trials

Read Article

Zymeworks Completes Acquisition of Kairos Therapeutics Creating a Leader in Biologics Drug Discovery and Development

Read Article

Zymeworks Announces $61.5M Financing to Support the Clinical Development of its Pipeline of Azymetric™ Antibody Therapeutics

Read Article

Investissement Québec invests 10M in CTI Life Sciences Fund II

Read Article

PHEMI Closes $12.2M Venture Financing

Read Article

SutroVax raises $22M in Series A

Read Article

XTuit Pharmaceuticals Closes $22M Series A Financing to Advance Novel Microenvironmental Modulators for Cancers and Fibrotic Disorders

Read Article

Impressive Industry Leaders Elected to BIOTECanada Board of Directors

Read Article

NEOMED Announces Appointment of Dr. Laurence Rulleau to its Board of Directors

Read Article

Zymeworks Announces Bi-Specific Antibody Collaboration with Celgene

Read Article

CTI Life Sciences successfully raises new C$ 134 Million venture capital fund

Read Article

Xagenic Announces Second Closing of $25.5M Series B Financing

Read Article

Medicago announces agreement to be acquired by Mitsubishi Tanabe Pharma in a transaction valued at $357M

Read Article

Fonds de solidarité FTQ, CTI Life Sciences Fund and Ferring Pharmaceuticals Create a New Biotech in Québec

Read Article

Closing of acquisition of Enobia by Alexion – Yet another successful portfolio exit for CTI Life Sciences Fund

Read Article

Xagenic Inc. Closes C$10M Series A Financing

Read Article

Alexion to Acquire Enobia Pharma Corp. and First Potential Treatment for Patients with Hypophosphatasia (HPP)

Read Article

Medicago Completes $25M Private Placement

Read Article